Kristin Beale

Goodwin

+ Follow Contact

Latest Posts › FDA Approval

Share:

Celltrion Announces Commercial Availability of ZYMFENTRA™ (infliximab-dyyb)

Celltrion USA announced on March 18, 2024, the availability of ZYMFENTRA™ (infliximab-dyyb), a subcutaneous (SC) formulation of infliximab…...more

3/20/2024 / Biologics , Biosimilars , FDA Approval , Food and Drug Administration (FDA) , Life Sciences , Pharmaceutical Industry , Prescription Drugs

FDA Approves VABYSMO (faricimab) for Retinal Vein Occlusion

On October 26, 2023, Genentech, a member of the Roche Group, announced that the FDA approved VABYSMO (faricimab-svoa) for the treatment of macular edema following retinal vein occlusion (RVO). ...more

11/7/2023 / FDA Approval , Genentech , Pharmaceutical Industry , Prescription Drugs

Sandoz Receives FDA Approval for Tyruko® (natalizumab-sztn), the First and Only FDA-Approved Biosimilar for Relapsing Forms of...

On August 25, 2023, Sandoz announced that the FDA has approved its biosimilar Tyruko® (natalizumab-sztn), developed by Polpharma Biologics. Tyruko® injection is the first and only FDA-approved biosimilar for relapsing...more

9/13/2023 / Biosimilars , FDA Approval , Food and Drug Administration (FDA) , Pharmaceutical Industry , Prescription Drugs

3 Results

View per page

Page: of 1